Lynch Casey
Chief Executive Officer at IRLA
- Sold, on record
- $4.4M
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 10, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- IRLAIRulya Therapeutics Inc.Chief Executive Officer
Sales by reason
0
Routine
3
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale IRLAPlan not statedFeb 3, 2021 2021
Sold 60,000 shares at $38.49 ($2.3M)
Lynch Casey, Chief Executive Officer
Sold 5.5% of holdings ($42.3M position)1M shares leftFirst sale on recordFiling
- 2 Form 4 sale IRLAPlan not statedMar 22, 2021 +47 days
Sold 30,000 shares at $35.59 ($1.1M)
Lynch Casey, Chief Executive Officer
Sold 2.9% of holdings ($37M position)1M shares leftFiling
- 3 Form 4 sale IRLAPlan not statedMay 10, 2021 +49 days
Sold 30,000 shares at $34.58 ($1M)
Lynch Casey, Chief Executive Officer
Sold 3% of holdings ($34.9M position)978,774 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2021 | May 12, 2021 | IRLA | Chief Executive Officer | Form 4 sale | 30,000 | $1M | 3.0% | Plan not stated | SEC |
| Mar 22, 2021 | Mar 23, 2021 | IRLA | Chief Executive Officer | Form 4 sale | 30,000 | $1.1M | 2.9% | Plan not stated | SEC |
| Feb 3, 2021 | Feb 3, 2021 | IRLA | Chief Executive Officer | Form 4 sale | 60,000 | $2.3M | 5.5% | Plan not stated | SEC |